Babraham Research Campus

Heading to #BioTrinity? So is François-Xavier Robert. Get in touch with him directly if you'd like to catch up.

The fourth annual The Babraham Institute Spectral Flow Cytometry Symposium will take place on 9-10 July. Secure your spot and register now for two days of talks from leading experts plus practical sessions and classroom-based workshops. What to expect? 🌟Listen to talks from international leading academic and industry experts detailing the full spectral cytometry technology and analysis methods. 🌟Take part in hands-on workshops to explore a range of cutting-edge equipment and analysis techniques. 🌟Meet with technical specialists from leading flow cytometry companies, explore a range of cutting-edge equipment offered by exhibiting companies. 🎟️ https://ow.ly/jQIA50Vk8El

If you're on Campus today head to the Market Restaurant before 3pm to speak with the RxCelerate team and find out more about how the range of services they offer could support your science. The Campus-based company was founded in 2013 and is now one of the leading providers of drug discovery and development services in the UK. Clients can also access RxCelerate’s proprietary platform technologies, including RxNfinity™ for rapid in silico screening, the Galaxy® platform for generating diverse ‘clinic-ready’ antibodies, and ProQuant® for precise bottom-up proteomics across diverse biological samples. The combination of integrated teams and unique technologies allows RxCelerate to deliver pharma-grade drug candidates quickly and at a fraction of the cost of traditional approaches. Visit the website for more details - https://ow.ly/IbRX50VjOXN

Time is running out to apply for another key role within Cambridge NeuroWorks! ⏳ Babraham Research Campus is looking for a Fellowship Coordinator to help support the delivery of our Cambridge NeuroWorks programme. If you'd like to support the coordination of up to six Fellows, advancing neurotechnology innovation - this role is for you! But be quick...the deadline is looming ⏳ apply by 31st March ⬇

Campus-based ExpressionEdits has welcomed Dr Amrik Basran as Chief Scientific Officer to lead the translation of its intronization technology into a pipeline of innovative therapeutics, starting with recombinant protein therapeutics. Dr Basran has over two decades of experience in biologic drug discovery and development, spanning early-stage research to clinical application. His focus at Expression Edits will be on advancing the company’s internal programs from early research through clinical translation, ensuring that its cutting-edge gene optimization platform directly drives the development of next-generation biologic medicines. Full story 👇 https://ow.ly/OXGx50VjSaC

A new BBSRC-funded project will explore innovative approaches to faster, more efficient and safer cell reprogramming through a collaboration between The Babraham Institute and Campus-based Axol Bioscience Ltd. The partnership will combine new knowledge and tools developed in the Christophorou lab in collaboration with Dr Louise Walport at the Francis Crick Institute, with the expertise and state-of-the-art cell reprogramming platform established by Axol Bioscience. This academic-commercial project is made possible thanks to the unique tranche of funding available through the UKRI-BBSRC Campus Innovation Award that allows Campus-based teams to leverage each other's expertise and resources to maximise impact. Full story 👇 https://ow.ly/HPQJ50VkBCq

On Thursday Revvity hosts a 'High Content Imaging & Analysis' seminar with guest speakers from Campus-based Artiosand Talisman Therapeutics Limited. 🕑11.30am-1pm 📍Queen Edith’s Room

📢Job alert! We're looking for a Fellowship Coordinator to play a key role in advancing neurotechnology innovation within Cambridge NeuroWorks. 🧠 The successful candidate will support the Fellowship Operations Manager in the delivery of the Cambridge NeuroWorks programme and work closely with our other ARIA activation partners. It's an exciting role which will involve a variety of responsibilities including: 🌟co-ordination of up to six Fellows annually, conducting their individual 12-month fellowships 🌟scheduling meetings, organising papers, contracts and invoices for Fellows hosted within our LiveLabs facility 🌟administration of the Cambridge NeuroWorks Frontier fellowship programme 🌟helping to deliver a neurotech theme as part of Accelerate@Babraham. 🌟ensuring training records for each Fellow are up to date, irrespective of where the Fellow is hosted. This is a fixed term contract up to 30 Sept 2027 with a salary of £32,000-36,000. The closing date is 31 March. You can find the full details including how to apply 👇 https://ow.ly/fJy950VjPmK

🥼🔬Earlier this month the The Babraham Institute hosted Schools' Day and welcomed more than 190 students to take part in experiments and bioinformatics analysis hosted by 19 of the Institute’s research groups and three Campus companies - Cancer Research Horizons, CREASALLIS and Xap Therapeutics. 💡This is such a valuable public engagement initiative to inspire the scientists of the future and we're really grateful to all those who shared their time and knowledge. 💬These testimonials from those involved highlight the benefits of Schools' Day and give a taste of the insights gained by the students: “We’re really pleased that Cancer Research Horizons was able to participate in School’s Day again this year. The students were able to carry out laboratory techniques that we use on a daily basis, giving them valuable insight into the life of a medicinal chemist, and hopefully inspiring them to pursue careers in STEM.” Katherine Hazel, Senior Scientist, Cancer Research Horizons “I want to be able to share my journey as a scientist. There are truly wonderful moments that can happen in research and to be part of a mission to improve the quality of patients’ life is the main motivation for why I am in the Cell & Gene therapies space. I want all the students to realise that they all have the potential to be a scientist regardless of age, gender, background etc. Failure does happen but it’s important for them to know it’s an important driver of success.” Khashayar Khoshrou, Senior Research Associate, Xap Therapeutics More 👇 https://ow.ly/3j8B50VfTr3

Our Chief Scientific and Innovation Officer Louise Jopling is a speaker at next month's Why Summits Pharma Partnering Conference taking place in Basel. The conference will bring together industry leaders, biotech innovators, and investors to explore how strategic partnerships can accelerate drug development, enhance innovation, and improve patient outcomes. Louise will be sharing her insights on the panel for a discussion covering deal making in pharma and biotech. Find out more on the event website 👇 https://ow.ly/b4tw50VfGl3